137 Ventures Closes $700M Across Two New Funds, Pushing AUM Past $15B Ahead of SpaceX IPO
TL;DR
137 Ventures has closed more than $700 million across two new vehicles, pushing the San Francisco growth-stage firm past $15 billion in assets under management. The pair of funds, raised on the doorstep of an expected SpaceX IPO, doubles down on the strategy that has made 137 one of the most distinctive shareholder-liquidity providers in late-stage tech: equity loans, secondary purchases, and structured tenders into the world's most capital-hungry private companies.
Key Takeaways
Two vehicles, one playbook. One fund will pursue primary investments and tender offers, while the second is a dedicated sleeve for founders and employees of 137's existing portfolio. Splitting the structure lets the firm price secondary liquidity and primary growth checks differently, which matters when the underlying companies trade across radically different volatility regimes.
The SpaceX trade is the franchise. 137's stake in SpaceX has now crossed 1% and is reportedly worth more than $10 billion on paper. Raising $700 million right before a potential Musk-led IPO is not a coincidence; it gives the firm dry powder to backstop tenders, recycle exposure, and capture upside as the float opens up.
Defense and AI infrastructure dominate the recent book. Recent checks went to Cognition, Impulse Space, Hadrian, and Physical Intelligence. That portfolio reads less like a classic growth fund and more like a thesis on American industrial reindustrialization, sovereign tech, and the AI capex cycle.
$15B AUM puts 137 in rare company. Few specialist secondary-and-growth shops have crossed the $10B mark, let alone $15B. At this scale, 137 starts to compete with platform-style allocators like Coatue and Iconiq, even though its DNA remains private-shareholder liquidity rather than public-market crossover.
Fund Overview
Fund Name: 137 Ventures (two new vehicles, names not disclosed)
Fund Size: Over $700 million combined
Stage: Late-stage growth and secondaries
Check Size: Typically $25M to $100M+ across primaries, tenders, and equity loans
Geography: Global, US-led
Focus: AI, defense, advanced industrials, frontier tech
Key LPs: Existing institutional LPs base; nine institutional funds raised since inception
Why This Fund Matters
Public markets have been broken as an exit channel for the highest-quality private tech companies. SpaceX, Stripe, Anthropic, OpenAI, Anduril, Ramp, and a dozen others have stayed private not because they cannot list, but because they do not need to. That dynamic created a vacuum, and 137 Ventures has been one of the firms most aggressive in filling it.
The model is straightforward in concept and operationally complex in practice. 137 either lends against shareholder equity, buys secondaries directly from employees and early investors, or anchors company-organized tender offers. In each case, it gets exposure to private companies it could not otherwise build a position in at scale, while founders and operators get partial liquidity without forcing a sale of the company.
What is interesting in 2026 is the timing. With SpaceX speculated to IPO in the next 12 to 24 months and a wave of AI infrastructure companies sitting on enormous paper marks, secondary demand has exploded. 137's $700 million is a bet that this demand is not a 2024 to 2026 anomaly, but a structural feature of how the most valuable private companies will fund themselves for the next decade.
The risk, of course, is mark-to-market exposure. If a single anchor position like SpaceX revalues sharply downward, the entire AUM number compresses. 137 has navigated these cycles before, but at $15B AUM the gravitational pull of a few mega-positions is non-trivial.
The Team
Founder and Managing Partner Justin Fishner-Wolfson built 137 Ventures around the insight that private-market liquidity would become a permanent asset class. The firm has now raised nine institutional funds plus dedicated co-invest and continuation vehicles, and has deployed more than $1.7 billion over the last 12 months alone. The team's edge is structural: relationships with founders and CFOs that give it first look at tender flow, and an operational framework for pricing illiquid private-company equity at scale.
Early Portfolio
Public portfolio names include SpaceX, Stripe, Anduril, Ramp, Gusto, Cognition, Impulse Space, Hadrian, and Physical Intelligence. The recent emphasis is unmistakable: AI labs and applied-AI companies, defense and dual-use industrials, and infrastructure plays that benefit from American reshoring.
What This Means for Founders
If you are running a late-stage company, 137 is a phone call worth making before your next round. Their checks tend to come without the governance friction of a primary lead, and they can operate fast on tenders and structured liquidity programs. For founders who do not want to dilute further but need to give early employees and angels a path to cash, this is one of a small number of credible counterparties at scale.
For early-stage founders the relevance is more indirect. 137's growing AUM is a downstream signal that the late-stage liquidity market is institutionalizing, which makes secondaries an increasingly viable path two or three rounds in. Plan your cap table accordingly.
Fund Momentum Take
137 has quietly become one of the most important capital allocators in private tech, and almost no one outside Sand Hill Road talks about it that way. The firm sits at the seam between traditional growth equity and structured private credit, and at $15B AUM it has the balance sheet to keep widening that seam.
Our bet: if SpaceX prices at $400B+ within the next 18 months, 137 books one of the most lucrative single-position outcomes in venture history, and a third $1B+ fund follows almost immediately. If SpaceX delays or marks down, 137's AUM compresses, but the franchise survives because the underlying secondary demand does not go away. The model is anti-fragile by design.
The real risk to watch is competition. Iconiq, Coatue, ALTSV, and a wave of dedicated secondary funds are now elbowing into the same trade. Pricing discipline will matter more in the next cycle than it did in the last one.
Frequently Asked Questions
What does 137 Ventures actually invest in?
It buys equity in late-stage private tech companies through secondary purchases, structured equity loans to shareholders, and primary investments alongside tender offers. Public portfolio includes SpaceX, Stripe, Anduril, Ramp, Cognition, and Hadrian.
How big are 137's checks?
Individual deals range from tens of millions to several hundred million dollars depending on whether the check is a primary investment, a tender, or an aggregated employee secondary purchase.
Why does the SpaceX position matter so much?
Reports indicate 137's stake has crossed 1% of SpaceX, worth more than $10 billion on paper. That single position drives a meaningful share of the firm's $15B AUM and is a primary source of expected near-term liquidity.
Is this a venture fund or a secondaries fund?
Both. 137 sits in a hybrid category often called "structured liquidity" or "growth secondaries," combining primary growth checks with extensive secondary and tender activity.
How do founders engage with 137 Ventures?
Late-stage companies typically engage 137 either when running a tender offer or when seeking a buyer for sizable employee or angel secondary blocks. The firm prefers to lead or anchor these processes rather than passively participate.
Have a fund closing to announce? Submit your fund here.
Need help raising capital? Check out our Fundraising Advisory services.